Trending Stories
From the latest healthcare headlines to MedAxiom community news, this is the place to learn more and stay informed. Updated regularly.
Benefits for the Conversion of OBL to a Hybrid OBL/ASC
Partner News | Published: Thursday, June 4, 2020
By: Robert J. Zasa, CEO, ACA Cardiovascular, LLC and rzasa@acacardiovascular.com Heather Combs, RN , COO, ACA Cardiovascular hcombs@acacardiovascular.com Interventional cardiovascularSurvey: Cardiac Implantable Electronic Device Data
News | Published: Tuesday, June 2, 2020
The Research Team at the Parkview Mirro Center for Research and Innovation in Fort Wayne, IN, in partnership with the Heart Rhythm Society Interoperability Workgroup, is exploring clinician preferences and use of cardiac implantable electronic device (CIED) data elements in the clinical decision process.
MedAxiom Announces Industry Partnership With Cell>Point
Partner News | Published: Monday, June 1, 2020
Cell>Point, LLC. is a leader in the development and commercialization of molecular imaging and targeted therapeutics.
The Benefits of a Sale-Leaseback Real Estate Transaction
Partner News | Published: Wednesday, May 20, 2020
Many factors influence your decision to execute a sale-leaseback of your building, including deal terms, asset location, strength of the practice, and tenure of the physicians. In this white paper from Physicians Realty Trust, a trusted industry partner, learn what factors to consider as you determine if the timing is right to look at a potential sale-leaseback for your real estate.
Cardiac imaging company Genetesis adds TDK Ventures as strategic investor
Partner News | Published: Wednesday, May 13, 2020
Genetesis Inc, a MedAxiom partner and medical technology company that has developed non-invasive, biomagnetic CardioFlux™ imaging, has announced several important updates. The company has closedKeeping Your Patient Appointment Schedule Intact During (and After) the COVID-19 Pandemic
Partner News | Published: Monday, May 11, 2020
Medical practices are working through multiple issues brought on by the COVID-19 pandemic: supplying needed care for patients, uncertainties in staffing, PPE supply, PPP funding, and preserving revenue. SomeFarxiga approved in the US for the treatment of heart failure in patients with heart failure with reduced ejection fraction
Partner News | Published: Thursday, May 7, 2020
AstraZeneca’s Farxiga (dapagliflozin) has been approved in the US to reduce the risk of cardiovascular (CV) death and hospitalisation for heart failure in adults with heart failure (NYHA class II-IV)A FAST, COMPREHENSIVE APPROACH FOR RE-OPENING YOUR CV SERVICE LINE
Partner News | Published: Monday, May 4, 2020
As we emerge from the unprecedented COVID-19 crisis, programs across the country are seeking a safe, rational approach to re-opening their Cath Labs and resuming elective revascularization. MedAxiom IndustryCMS Issues Second Interim-Final COVID-19 Rule
News | Published: Thursday, April 30, 2020
The Centers for Medicare and Medicaid Services (CMS) issued a second final-interim rule on April 30 that includes several key measures, including expanded access to COVID-19 testing and telehealth services.
TDK Ventures Invests in Biomagnetic Medical Imaging Company Genetesis
Partner News | Published: Wednesday, April 29, 2020
TDK Corporation (TSE:6762) announces that subsidiary TDK Ventures Inc. adds to its growing portfolio of companies with an investment in Genetesis, a world leader in non-invasive biomagnetic imaging. Genetesis